AI DErived Plaque Quantification: CCTA and AI-QCPA for Determining Effective CAD Management

AI DErived Plaque Quantification: CCTA and AI-QCPA for Determining Effective CAD Management

Conditions: Coronary Artery Disease
Interventions: Diagnostic Test: AI-enabled quantitative coronary plaque analysis (AI-QCPA)
Sponsors: HeartFlow, Inc.
Enrolling by invitation

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 20, 2024Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
Comments